Pembrolizumab Prior to Surgery for Stage 1B, 2 or 3A Non-small Cell Lung Cancer (NSCLC): A Phase II Study

Clinical Trial Grant

Duke Scholars

Principal Investigator Neal Edward Ready Medicine, Medical Oncology

Awarded By

Merck

Start Date

July 1, 2020

End Date

August 31, 2026

Awarded By

Merck

Start Date

July 1, 2020

End Date

August 31, 2026